Almond Milk and Fatty Liver: Is It a Good Choice?

Almond milk and fatty liver disease is a common dietary question, and the short answer is that unsweetened almond milk is a reasonable choice within a liver-friendly diet. Low in saturated fat and free from cholesterol, it fits the nutritional principles recommended by NHS and NICE guidance for managing metabolic dysfunction-associated steatotic liver disease (MASLD). However, it is not a treatment, and sweetened varieties can actively worsen liver fat accumulation. This article explains what the evidence says, which foods to avoid, and how NHS guidance approaches dietary management of fatty liver disease.

Is almond milk good for fatty liver disease?

Unsweetened almond milk is a reasonable choice for people with fatty liver disease because it is low in saturated fat and calories, but it is not a treatment and sweetened varieties can worsen liver fat due to their added sugar content.

Almond milk is a reasonable dairy alternative for people with fatty liver disease, primarily because it is low in saturated fat and contains no cholesterol, both of which are relevant to liver health. Fatty liver disease, known medically as metabolic dysfunction-associated steatotic liver disease (MASLD) or, in its alcohol-related form, alcohol-related liver disease (ALD), involves an accumulation of fat within liver cells.^[1][2] Reducing dietary saturated fat and overall calorie intake is a cornerstone of nutritional management, consistent with NHS and NICE guidance on MASLD, and unsweetened almond milk fits within that framework.^[3][5]

Almond milk is naturally low in calories compared with whole cow's milk, and it contains small amounts of vitamin E, an antioxidant that has attracted research interest in the context of liver inflammation. However, commercially produced almond milk contains only a small proportion of actual almonds, meaning the vitamin E content is modest. Food-based vitamin E from almond milk has not been shown to treat MASLD, and vitamin E supplements are not routinely recommended for this condition.^[5][6]

The key qualifier is the word "unsweetened". Many flavoured or sweetened almond milk products contain added sugars, including fructose, which can actively worsen hepatic fat accumulation.^[7][8] People with fatty liver disease should always check the nutrition label and choose unsweetened varieties. It is also worth checking whether the product is fortified with calcium, as almond milk is naturally low in calcium and iodine compared with cow's milk, and fortification varies between brands. Almond milk is also low in protein, so it is important to ensure adequate protein from other foods in the diet, particularly for those at risk of muscle loss.

Almond milk is not a treatment for fatty liver disease, and no single food or drink will reverse the condition on its own. It is best considered one small component of a broader dietary pattern focused on whole foods, reduced free sugars, and healthy fats.

What does the evidence say about diet and fatty liver?

The strongest evidence supports overall calorie reduction and a Mediterranean-style dietary pattern, rich in vegetables, wholegrains, oily fish, and olive oil, as the most effective nutritional approach for reducing liver fat and inflammation.

The strongest dietary evidence for managing fatty liver disease points to overall calorie reduction and a Mediterranean-style eating pattern as the most effective nutritional approaches. A Mediterranean diet, rich in vegetables, legumes, wholegrains, oily fish, olive oil, and nuts, has been associated in multiple observational and intervention studies with reductions in liver fat, liver enzyme levels, and markers of inflammation. This pattern naturally limits processed foods, refined carbohydrates, and red meat, all of which are associated with worsening liver steatosis. NICE guidance (NG49) and the EASL-EASD-EASO clinical practice guidance on MASLD both support a Mediterranean-style dietary pattern alongside calorie reduction as the primary nutritional approach.^[3][4]

Fructose, particularly in the form of sugar-sweetened beverages and ultra-processed foods, has been consistently identified in research as a driver of hepatic fat synthesis. Studies have shown that high fructose intake promotes de novo lipogenesis, the process by which the liver converts excess sugar into fat.^[7][9] UK dietary guidance, including the Scientific Advisory Committee on Nutrition (SACN) report on Carbohydrates and Health, recommends limiting free sugars, and this is especially relevant for people with fatty liver disease.^[11]

Coffee consumption has attracted scientific interest, with several observational studies and meta-analyses suggesting that regular coffee intake is associated with lower rates of liver fibrosis progression. These findings are observational and the mechanisms are not fully established; coffee cannot be recommended as a treatment.

Omega-3 fatty acids, found in oily fish such as salmon, mackerel, and sardines, have shown some benefit in reducing liver fat in clinical trials. However, evidence that omega-3 supplementation alone improves liver histology is less consistent, and omega-3 supplements are not routinely recommended specifically for MASLD in current UK or European guidance.^[5][6]

No single food, including almond milk, has been shown in robust clinical trials to independently reverse fatty liver disease. The evidence supports dietary patterns rather than individual foods.

Which foods and drinks should you avoid with fatty liver?

People with fatty liver disease should avoid alcohol, sugar-sweetened beverages, ultra-processed foods, refined carbohydrates, and red or processed meats, all of which are associated with worsening hepatic fat accumulation.

People with fatty liver disease should avoid or significantly limit alcohol. The UK Chief Medical Officers' low-risk drinking guidelines advise drinking no more than 14 units of alcohol per week, spread over three or more days, and avoiding binge drinking.^[14] For people with ALD or advanced liver fibrosis, specialist advice will typically recommend complete abstinence. Even for those with MASLD, where alcohol is not the primary cause, alcohol can worsen liver inflammation and fibrosis, and NHS guidance advises keeping within recommended limits or abstaining altogether.

Sugar-sweetened beverages, including fizzy drinks, fruit juices, energy drinks, and sweetened plant milks, should be avoided because of their high free sugar content. When choosing plant milks, check the label for added sugars and select unsweetened varieties. Ultra-processed foods, such as ready meals, crisps, biscuits, pastries, and fast food, are typically high in refined carbohydrates, saturated fat, and added sugars, all of which are associated with hepatic fat accumulation. Red and processed meats, including sausages, bacon, and deli meats, are best limited due to their saturated fat content and association with metabolic risk.

Refined carbohydrates, such as white bread, white rice, and sugary breakfast cereals, cause rapid rises in blood glucose and insulin, which in turn stimulate fat storage in the liver. Replacing these with wholegrains, such as oats, brown rice, and wholemeal bread, is a practical step supported by dietary guidance.

Industrial trans fats are uncommon in UK food products following industry reformulation, but may still be present in some imported or restaurant foods. It is worth checking labels on processed goods. Portion size also matters: even healthy foods consumed in excess can contribute to the calorie surplus that drives fatty liver progression.

What does NHS guidance say about managing fatty liver through diet?

NHS and NICE guidance (NG49) recommends lifestyle change, particularly a sustained weight loss of 7 to 10 per cent of body weight through dietary modification and physical activity, as the primary strategy for managing fatty liver disease.

NHS guidance on fatty liver disease emphasises that lifestyle change, particularly weight loss through a combination of dietary modification and increased physical activity, is the most effective way to reduce liver fat and prevent progression to more serious conditions such as liver fibrosis or cirrhosis. For people who are overweight or living with obesity, NICE guidance (NG49) indicates that a sustained weight loss of 7 to 10 per cent of body weight is associated with meaningful reductions in liver fat and inflammation.^[3]

Alongside dietary change, the UK Chief Medical Officers' Physical Activity Guidelines recommend at least 150 minutes of moderate-intensity activity per week, plus muscle-strengthening activities on two or more days per week.^[15][16] Physical activity supports weight loss and has independent benefits for metabolic health and liver fat reduction.

The NHS recommends a balanced diet based on the Eatwell Guide principles, which prioritises vegetables, fruit, wholegrains, lean protein, and dairy or fortified dairy alternatives, while limiting foods high in saturated fat, salt, and free sugars. Unsweetened, calcium-fortified almond milk can fit within this framework as a lower-calorie alternative to full-fat dairy, though it provides less protein and calcium than cow's milk unless fortified, so checking the label is advisable.

NICE guidance (NG49) recommends that people with fatty liver disease are offered structured lifestyle advice and, where appropriate, referral to a dietitian. In primary care, a blood test called FIB-4 is used to assess the risk of advanced liver fibrosis and to guide referral decisions.^[3] Where further assessment is needed, NICE guidance (DG11) supports the use of the Enhanced Liver Fibrosis (ELF) test to identify those who may need hepatology referral.^[17] People with more advanced liver disease may be referred to a hepatologist for further assessment and management.

At the time of writing, there is no licensed pharmacological treatment specifically for MASLD in the UK, making dietary and lifestyle intervention the primary management strategy. This position should be confirmed with your GP or specialist, as the treatment landscape may change.

If you are concerned about fatty liver disease, speak with your GP, who can arrange blood tests and imaging to assess liver health and refer you to specialist services if needed. Seek urgent medical attention, by calling 999 or going to an accident and emergency department, if you develop jaundice (yellowing of the skin or whites of the eyes), vomiting blood or passing black tarry stools, significant abdominal swelling, or sudden confusion. Contact NHS 111 or your GP promptly if you experience persistent fatigue, right-sided abdominal discomfort, severe itching, dark urine, or unexplained weight loss.

Scientific References

1. New Nomenclature for Nonalcoholic Fatty Liver Disease.
2. Global epidemiological patterns and disease burden of metabolic dysfunction-associated steatotic liver disease, metabolic dysfunction and alcohol-associated liver disease, and alcohol-associated liver disease.
3. Metabolic dysfunction-associated steatotic liver disease (NG49).
4. EASL-EASD-EASO Clinical Practice Guidelines on the Management of MASLD.
5. Non-alcoholic fatty liver disease (NAFLD).
6. Metabolic dysfunction-associated steatotic liver disease – recommendations for research (NG49).
7. The metabolic and molecular mechanisms linking fructose consumption to lipogenesis and metabolic disorders.
8. Circulating glycerate predicts resilience to fructose-induced hepatic steatosis.
9. Inhibition of ketohexokinase in adults with NAFLD reduces liver fat and inflammatory markers: A randomized phase 2 trial.
10. Lactose and sucrose each stimulate hepatic de novo lipogenesis: A randomized crossover trial.
11. SACN Carbohydrates and Health Report.
12. Effect of Coffee Consumption on Non-Alcoholic Fatty Liver Disease.
13. Omega-3 polyunsaturated fatty acids and nonalcoholic fatty liver disease in adults: A meta-analysis of randomized controlled trials.
14. Alcohol consumption: advice on low risk drinking – UK Chief Medical Officers' guidelines.
15. Physical activity guidelines: UK Chief Medical Officers' report.
16. Physical activity guidelines for adults aged 19 to 64.
17. Testing for advanced liver fibrosis – Enhanced Liver Fibrosis (ELF) test (QS152).
18. GID-TA11477 draft scope: Treatment of MASLD – no medicines currently approved in the UK.
19. Resmetirom (Rezdiffra) authorised to treat metabolic dysfunction-associated steatohepatitis (MASH) in adults.

Frequently Asked Questions